|
EP3257564B2 |
Overload And Elute Chromatography
|
29 May, 2024
| |
|
EP3294770B2 |
Therapeutic And Diagnostic Methods For Cancer
|
20 Mar, 2024
| |
|
EP2687202B1 |
Subcutaneous Anti-Her2 Antibody Formulation
|
10 May, 2023
| |
|
EP3303632B2 |
Therapeutic And Diagnostic Methods For Cancer
|
10 May, 2023
| |
|
EP3474729B1 |
Medical Device For Transcutaneously Inserting An Insertable Element Into A Body Tissue
|
19 Apr, 2023
| |
|
EP3903102B1 |
Ph-Gradient Spr-Based Binding Assay
|
12 Apr, 2023
| |
|
EP3417071B1 |
System And Method For Targeted Depletion Of Nucleic Acids
|
05 Apr, 2023
| |
|
EP3632488B1 |
Device For Sustained Delivery Of A Therapeutic Fluid
|
05 Apr, 2023
| |
|
EP3083686B2 |
Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes
|
22 Mar, 2023
| |
|
EP4085832A1 |
Non-invasive determination of blood glucose levels
|
09 Nov, 2022
| |
|
EP4076664A1 |
Egfr inhibitors
|
26 Oct, 2022
| |
|
EP4076665A1 |
Egfr inhibitors
|
26 Oct, 2022
| |
|
EP3512960B1 |
Methods For Performing Multiplexed Real-Time Pcr
|
19 Oct, 2022
| |
|
EP3213085B2 |
Biomarkers For Risk Prediction Of Mortality
|
28 Sep, 2022
| |
|
EP2582286B2 |
Structured Tailoring
|
21 Sep, 2022
| |
|
EP2926142B2 |
Identification Of Patients In Need Of Pd-L1 Inhibitor Cotherapy
|
06 Jul, 2022
| |
|
EP3989823A1 |
Determination of a concentration of an analyte in a bodily fluid by using a mobile device with a camera
|
04 May, 2022
| |
|
EP2575847B2 |
Methods Of Purifying Polypeptides
|
27 Apr, 2022
| |
|
EP3986565A1 |
New egfr inhibitors
|
27 Apr, 2022
| |
|
EP3986566A1 |
New egfr inhibitors
|
27 Apr, 2022
| |
|
EP3986567A1 |
New egfr inhibitors
|
27 Apr, 2022
| |
|
EP2218476B2 |
Leaf Spring Valve And Cone Membrane Valve
|
16 Mar, 2022
| |
|
EP3283099B1 |
Combination Therapy With Coagulation Factors And Multispecific Antibodies
|
02 Mar, 2022
| |
|
EP3424323B2 |
Growth Regulator And Fungicide
|
09 Feb, 2022
| |
|
EP3603801B1 |
Metal Oxide Catalyst, Method For Producing Same, And Method For Producing Alcohol Using Same
|
05 Jan, 2022
| |
|
EP3931348A1 |
Oligonucleotide formulation method
|
05 Jan, 2022
| |
